Phosphatase Inhibitors: Targeting Cancer and Immune Cells (IMAGE)
Caption
Druggable phosphatases in cancer and immune cells, with examples of their corresponding drugs. Structures of allosteric inhibitors targeting PP2A, PRL3, DUSP1/6, and SHP2 in cancer cells (left). Structures of catalytic inhibitors targeting SHP2, SHP1, PTPN2, PTP1B, and PTPN22 in immune cells (right). Figure created using Canva (www.canva.com).
Credit
Khaled Barakat
Usage Restrictions
Marked by the credited.
License
Original content